StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

CASI Pharmaceuticals's cash was $5.63M at Dec 31, 2025. For fiscal 2025 it was $5.63M, down 58.2% from the year before. The highest annual figure on record is $48.57M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.63M-58.2%
FY2024Dec 31, 2024$13.47M-53.7%
FY2023Dec 31, 2023$29.09M-40.1%
FY2022Dec 31, 2022$48.57M+0.0%
FY2021Dec 31, 2021$48.57M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$5.63M-88.4%
Q4 FY2024Dec 31, 2024$13.47M–
Q4 FY2023Dec 31, 2023$29.09M–
Q4 FY2022Dec 31, 2022$48.57M–
Q4 FY2021Dec 31, 2021$48.57M–

More CASI Pharmaceuticals figures

See a number that looks wrong?